Inpharmation predicts the current economic climate will lead to increased pharma IRP controls

Following the financial crisis in 2008/2009, there was a total of 93 changes to IRP rules implemented between 2008-2010. However, following Covid-19, there have been fewer than expected changes to IRP rules due to governments prioritizing their handling of the pandemic. We discuss the trends in IRP changes with economic crises and how pharma can best prepare for them.

Back to White Papers

Download the document by filling in the form:

By clicking on the “Submit Request” button you are providing consent for us to store your data and contact you. You may withdraw your consent at any time by instructing us at .

View our Privacy Policy for more information.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Scroll Top